United States · Platforms & data · MarketBeat

Labcorp’s Lab Growth Surges as $125 Million Reimbursement Risk Looms

Published by MarketBeat · United States 30 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Labcorp (NYSE:LH) Chief Financial Officer Julia Wang said strength in the company’s central laboratory business and diagnostic testing helped drive third-quarter growth, while management prepares for a potential reduction in government reimbursement rates in 2027. Speaking at the UBS Global Healthc

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

MarketWatch

Nvidia’s stock is on a losing streak not seen in 14 years. What comes next?

Seeking Alpha

Careful adjustment of policy is appropriate, says Susan Collins on 50 bps rate hike

The Motley Fool

Dyadic: 3 Key Takeaways for Long-Term Investors

Investing.com

Eagle Point Cred earnings beat by $0.12, revenue topped estimates

CNBC

Chicago Fed's Goolsbee says central bank 'has definitely got work to do' on inflation

Yahoo Finance

Australia B2B Buy Now Pay Later Market and Investment Opportunities Databook - Q2 2026 Update, 45+ KPIs and Forecasts to 2030 | GMV to Reach US$11.52 Billion as Embedded ...